The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Prediction of Serious Complications in Patients With Seemingly Stable Febrile Neutropenia: Validation of the Clinical Index of Stable Febrile Neutropenia in a Prospective Cohort of Patients From the FINITE Study
Open accessAbstract
Purpose: To validate a prognostic score predicting major complications in patients with solid tumors and seemingly stable episodes of febrile neutropenia (FN). The definition of clinical stability implies the absence of organ dysfunction, abnormalities in vital signs, and major infections. Patients and Methods: We developed the Clinical Index of Stable Febrile Neutropenia (CISNE), with six explanatory variables associated with serious complications: Eastern Cooperative Oncology Group performance status ≥ 2 (2 points), chronic obstructive pulmonary disease (1 point), chronic cardiovascular disease (1 point), mucositis of grade ≥ 2 (National Cancer Institute Common Toxicity Criteria; 1 point), monocytes < 200 per μL (1 point), and stress-induced hyperglycemia (2 points). We integrated these factors into a score ranging from 0 to 8, which classifies patients into three prognostic classes: low (0 points), intermediate (1 to 2 points), and high risk (≥ 3 points). We present a multicenter validation of CISNE. Results: We prospectively recruited 1,133 patients with seemingly stable FN from 25 hospitals. Complication rates in the training and validation subsets, respectively, were 1.1% and 1.1% in low-, 6.1% and 6.2% in intermediate-, and 32.5% and 36% in high-risk patients; mortality rates within each class were 0% in low-, 1.6% and 0% in intermediate-, and 4.3% and 3.1% in high-risk patients. Areas under the receiver operating characteristic curves in the validation subset were 0.652 (95% CI, 0.598 to 0.703) for Talcott, 0.721 (95% CI, 0.669 to 0.768) for Multinational Association for Supportive Care in Cancer (MASCC), and 0.868 (95% CI, 0.827 to 0.903) for CISNE (P = .002 for comparison between CISNE and MASCC). Conclusion: CISNE is a valid model for accurately classifying patients with cancer with seemingly stable FN episodes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanley, J. A., & McNeil, B. J. (1983) · Radiology · doi:10.1148/radiology.148.3.6878708 · Cited by 7,016
Peduzzi, P., Concato, J., Feinstein, A. R., & Holford, T. R. (1995) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(95)00048-8 · Cited by 2,154
Flowers, C. R., Seidenfeld, J., Bow, E. J., Karten, C., Gleason, C., Hawley, D. K., Kuderer, N. M., Langston, A. A., Marr, K. A., Rolston, K. V. I., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.8661 · Cited by 448
Cited by
Taplitz, R. A., Kennedy, E. B., Bow, E. J., Crews, J., Gleason, C., Hawley, D. K., Langston, A. A., Nastoupil, L. J., Rajotte, M., Rolston, K. V., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.18.00374 · Cited by 601
Taplitz, R. A., Kennedy, E. B., Bow, E. J., Crews, J., Gleason, C., Hawley, D. K., Langston, A. A., Nastoupil, L. J., Rajotte, M., Rolston, K., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.77.6211 · Cited by 426
“for FN, a population that has been difficult to assess accurately in the past.(3) Antimicrobial prophylaxis recommendations are not included in this guideline update; they will be updated in”
BackgroundMethodInfluential(2021) · doi:10.3322/caac.21697 · Cited by 201
Best Practices for Reducing Unplanned Acute Care for Patients With Cancer
Handley, N. R., Schuchter, L. M., & Bekelman, J. E. (2018) · Journal of Oncology Practice · doi:10.1200/jop.17.00081 · Cited by 137
Metadata
- Authors
- Carmona-Bayonas, A., Jiménez-Fonseca, P., Virizuela Echaburu, J., Antonio, M., Font, C., Biosca, M., Ramchandani, A., Martínez, J., Hernando Cubero, J., Espinosa, J., Martínez de Castro, E., Ghanem, I., Beato, C., Blasco, A., Garrido, M., Bonilla, Y., Mondéjar, R., Arcusa Lanza, M. Á., Aragón Manrique, I., Manzano, A., Sevillano, E., Castañón, E., Cardona, M., Gallardo Martín, E., Pérez Armillas, Q., Sánchez Lasheras, F., & Ayala de la Peña, F.
- Venue
- Journal of Clinical Oncology
- Published
- 2015-02-10
- Volume
- 33
- Issue
- 5
- Pages
- 465-471
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2129964772
- Cited by
- 160
- References
- 3
- FWCI
- 5.98
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prediction of Serious Complications in Patients With Seemingly Stable Febrile Neutropenia: Validation of the Clinical Index of Stable Febrile Neutropenia in a Prospective Cohort of Patients From the FINITE Study. https://app.cochat.ai/papers/10.1200/jco.2014.57.2347
- The paper
- Carmona-Bayonas, A., Jiménez-Fonseca, P., Virizuela Echaburu, J., Antonio, M., Font, C., Biosca, M., Ramchandani, A., Martínez, J., Hernando Cubero, J., Espinosa, J., Martínez de Castro, E., Ghanem, I., Beato, C., Blasco, A., Garrido, M., Bonilla, Y., Mondéjar, R., Arcusa Lanza, M. Á., Aragón Manrique, I., . . . Ayala de la Peña, F. (2015). Prediction of Serious Complications in Patients With Seemingly Stable Febrile Neutropenia: Validation of the Clinical Index of Stable Febrile Neutropenia in a Prospective Cohort of Patients From the FINITE Study. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2014.57.2347
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.